# H1-5

## Overview
H1-5 is a gene that encodes the H1.5 linker histone, a protein integral to chromatin structure and gene regulation. As a member of the histone H1 family, H1.5 plays a pivotal role in the compaction of DNA into nucleosomes, thereby influencing chromatin architecture and gene expression. The H1.5 protein is characterized by its three-domain structure, which includes an unstructured N-terminal domain, a central globular domain, and an unstructured C-terminal domain. These domains facilitate its interaction with nucleosomal and linker DNA, contributing to chromatin condensation and stabilization. H1.5 is particularly active in differentiated cells, where it helps maintain a repressive chromatin state, thereby regulating gene expression and alternative splicing. Its interactions with various transcription factors and involvement in post-translational modifications further underscore its role in cellular processes. Alterations in H1-5 expression and mutations have been linked to several cancers and developmental disorders, highlighting its clinical significance (Ciolfi2020Frameshift; Li2012Dynamic; Behrends2020Linker).

## Structure
The H1-5 linker histone, also known as H1.5, is a protein involved in chromatin structure and gene regulation. It is part of the histone H1 family, which plays a crucial role in compacting DNA into nucleosomes. The primary structure of H1-5 consists of approximately 200 amino acids organized into three distinct domains: an unstructured N-terminal domain (NTD), a central globular domain (GD), and an unstructured C-terminal domain (CTD) (Kalashnikova2016Linker).

The globular domain of H1-5 features a winged helix structure, comprising three α helices and a small β strand, which allows it to interact with nucleosomal DNA (Lyubitelev2016Structure). This domain binds to the nucleosome without displacement relative to the symmetry axis, with specific residues interacting with nucleosomal DNA and linker DNA (Lyubitelev2016Structure).

The C-terminal domain is highly basic, enriched with lysine, alanine, and proline, and carries a high positive charge. It is unstructured in solution but forms a compact globule upon DNA binding, which is essential for chromatin condensation and polynucleosome oligomerization (Lyubitelev2016Structure). Post-translational modifications, such as phosphorylation, can modulate the function and binding affinity of H1-5, impacting chromatin architecture (Watson2019Disordered).

## Function
H1-5, also known as H1.5, is a linker histone that plays a critical role in chromatin organization and gene expression regulation in healthy human cells. It is involved in the compaction of chromatin into higher-order structures, which influences DNA accessibility and stabilizes nucleosome spacing (Behrends2020Linker). H1.5 is primarily active in the nucleus, where it contributes to the formation of compact chromatin blocks, particularly in differentiated cells. This compaction is essential for maintaining a 'closed' chromatin structure, which is associated with transcriptional repression (Li2012Dynamic).

H1.5 is known to bind preferentially to genes encoding membrane-related proteins and is associated with repressive chromatin elements such as SIRT1 and H3K9me2. This binding is necessary for chromatin compaction and gene repression, as depletion of H1.5 leads to increased chromatin accessibility and deregulation of gene expression (Li2012Dynamic). H1.5 also plays a role in regulating alternative splicing by causing RNA polymerase II pausing, which stabilizes nucleosomes and allows for the inclusion of alternatively spliced exons into mature mRNA (Behrends2020Linker).

Overall, H1.5 is crucial for maintaining proper gene expression patterns and chromatin structure, influencing cell growth and differentiation (Li2012Dynamic).

## Clinical Significance
Mutations and alterations in the expression of the H1-5 gene have been implicated in various cancers. In colorectal cancer and follicular lymphomas, mutations in H1.5 interfere with the binding of DNA-methyltransferase 3B, affecting epigenetic marks and potentially contributing to tumorigenesis (Behrends2020Linker). In prostate cancer, H1.5 expression is absent in benign glands but increases with higher Gleason scores, suggesting its potential as a prognostic marker. Overexpression of H1.5 in prostate cancer may repress prostatic genes and contribute to cancer aggressiveness through mechanisms such as alternative splicing of the androgen receptor (Behrends2020Linker).

In glioblastomas, H1.5 interacts with nucleophosmin (NPM1), and its reduction can reactivate apoptotic pathways, indicating a role in regulating apoptosis. Phosphorylation of H1.5 by glycogen synthase kinase 3 (GSK3) is involved in Ras-mediated glioma progression, affecting cell growth and migration (Behrends2020Linker). In breast cancer, tyrosine phosphorylation of H1.5 at Y74, mediated by Focal Adhesion Kinase (FAK), is higher in cancer cells, suggesting a role in tumor progression (Kumar2023PostTranslation).

H1.5 is also associated with Rahman syndrome, a developmental disorder characterized by intellectual disability and distinctive facial features. Frameshift mutations in the HIST1H1E gene, which encodes H1.5, result in a specific DNA hypomethylation signature linked to this syndrome (Ciolfi2020Frameshift).

## Interactions
H1-5, also known as H1.5, is a linker histone that plays a significant role in chromatin organization and gene regulation through its interactions with nucleic acids and proteins. H1.5 binds to linker DNA between nucleosomes, stabilizing chromatin structure and influencing gene expression (Kalashnikova2016Linker). The C-terminal domain (CTD) of H1.5 is crucial for chromatin compaction and interacts with DNA to neutralize its negative charge, facilitating chromatin stabilization (Hao2021Unraveling).

H1.5 also interacts with various transcription factors, such as Msx1 and FoxP3, affecting chromatin states and gene expression. In murine satellite cells, H1.5 forms a heterodimer with Msx1, promoting a repressive chromatin state at the MyoD enhancer (Behrends2020Linker). In human T-regulatory cells, FoxP3 enhances H1.5 binding to the IL-2 promoter, leading to histone deacetylation and reduced IL-2 expression (Behrends2020Linker).

H1.5 is involved in alternative splicing by pausing RNA polymerase II, which increases the inclusion of alternatively spliced exons into mature mRNA (Behrends2020Linker). These interactions highlight H1.5's role in regulating chromatin architecture and gene expression through its dynamic interactions with DNA and proteins.


## References


[1. (Hao2021Unraveling) Fanfan Hao, Seyit Kale, Stefan Dimitrov, and Jeffrey J. Hayes. Unraveling linker histone interactions in nucleosomes. Current Opinion in Structural Biology, 71:87–93, December 2021. URL: http://dx.doi.org/10.1016/j.sbi.2021.06.001, doi:10.1016/j.sbi.2021.06.001. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.sbi.2021.06.001)

[2. (Li2012Dynamic) Jing-Yu Li, Michaela Patterson, Hanna K. A. Mikkola, William E. Lowry, and Siavash K. Kurdistani. Dynamic distribution of linker histone h1.5 in cellular differentiation. PLoS Genetics, 8(8):e1002879, August 2012. URL: http://dx.doi.org/10.1371/journal.pgen.1002879, doi:10.1371/journal.pgen.1002879. This article has 70 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1002879)

[3. (Behrends2020Linker) Marthe Behrends and Olivia Engmann. Linker histone h1.5 is an underestimated factor in differentiation and carcinogenesis. Environmental Epigenetics, January 2020. URL: http://dx.doi.org/10.1093/eep/dvaa013, doi:10.1093/eep/dvaa013. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/eep/dvaa013)

[4. (Watson2019Disordered) Matthew Watson and Katherine Stott. Disordered domains in chromatin-binding proteins. Essays in Biochemistry, 63(1):147–156, April 2019. URL: http://dx.doi.org/10.1042/ebc20180068, doi:10.1042/ebc20180068. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/ebc20180068)

[5. (Lyubitelev2016Structure) A. V. Lyubitelev, D. V. Nikitin, A. K. Shaytan, V. M. Studitsky, and M. P. Kirpichnikov. Structure and functions of linker histones. Biochemistry (Moscow), 81(3):213–223, March 2016. URL: http://dx.doi.org/10.1134/S0006297916030032, doi:10.1134/s0006297916030032. This article has 21 citations.](https://doi.org/10.1134/S0006297916030032)

[6. (Kalashnikova2016Linker) Anna A. Kalashnikova, Ryan A. Rogge, and Jeffrey C. Hansen. Linker histone h1 and protein–protein interactions. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1859(3):455–461, March 2016. URL: http://dx.doi.org/10.1016/j.bbagrm.2015.10.004, doi:10.1016/j.bbagrm.2015.10.004. This article has 60 citations.](https://doi.org/10.1016/j.bbagrm.2015.10.004)

[7. (Kumar2023PostTranslation) Ashok Kumar, Preeti Maurya, and Jeffrey J. Hayes. Post-translation modifications and mutations of human linker histone subtypes: their manifestation in disease. International Journal of Molecular Sciences, 24(2):1463, January 2023. URL: http://dx.doi.org/10.3390/ijms24021463, doi:10.3390/ijms24021463. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24021463)

[8. (Ciolfi2020Frameshift) Andrea Ciolfi, Erfan Aref-Eshghi, Simone Pizzi, Lucia Pedace, Evelina Miele, Jennifer Kerkhof, Elisabetta Flex, Simone Martinelli, Francesca Clementina Radio, Claudia A. L. Ruivenkamp, Gijs W. E. Santen, Emilia Bijlsma, Daniela Barge-Schaapveld, Katrin Ounap, Victoria Mok Siu, R. Frank Kooy, Bruno Dallapiccola, Bekim Sadikovic, and Marco Tartaglia. Frameshift mutations at the c-terminus of hist1h1e result in a specific dna hypomethylation signature. Clinical Epigenetics, January 2020. URL: http://dx.doi.org/10.1186/s13148-019-0804-0, doi:10.1186/s13148-019-0804-0. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13148-019-0804-0)